# PARSABIV
> **NDA208325** · New Drug Application · Sponsor: KAI PHARMS INC · Approved 2017-02-07
## Drug
- **FDA Application Number:** NDA208325
- **Application type:** New Drug Application
- **Brand name:** PARSABIV
- **Generic name:** ETELCALCETIDE
- **Active ingredients:** ETELCALCETIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** KAI PHARMS INC
- **Manufacturer:** Amgen, Inc
- **First approval:** 2017-02-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208325)
---
*MORVS · CC0 1.0*